651 related articles for article (PubMed ID: 29409457)
21. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
22. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
[TBL] [Abstract][Full Text] [Related]
23. [Predictive factors associated with pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Sun Y; Chi P; Xu B; Lin H; Lu X; Huang Y; Xu Z; Huang S; Jiang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):556-60. PubMed ID: 24953361
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
Dreussi E; Cecchin E; Polesel J; Canzonieri V; Agostini M; Boso C; Belluco C; Buonadonna A; Lonardi S; Bergamo F; Gagno S; De Mattia E; Pucciarelli S; De Paoli A; Toffoli G
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608007
[TBL] [Abstract][Full Text] [Related]
25. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
Ryan JE; Warrier SK; Lynch AC; Ramsay RG; Phillips WA; Heriot AG
Colorectal Dis; 2016 Mar; 18(3):234-46. PubMed ID: 26531759
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
[TBL] [Abstract][Full Text] [Related]
27. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
[TBL] [Abstract][Full Text] [Related]
28. Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Lim SH; Chua W; Henderson C; Ng W; Shin JS; Chantrill L; Asghari R; Lee CS; Spring KJ; de Souza P
Crit Rev Oncol Hematol; 2015 Oct; 96(1):67-80. PubMed ID: 26032919
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy.
Ma WJ; Gu YK; Peng JH; Wang XC; Yue X; Pan ZZ; Chen G; Xu HN; Zhou ZG; Zhang RX
Aging (Albany NY); 2018 Oct; 10(10):2755-2771. PubMed ID: 30341253
[TBL] [Abstract][Full Text] [Related]
30. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.
Kong JC; Guerra GR; Warrier SK; Lynch AC; Michael M; Ngan SY; Phillips W; Ramsay G; Heriot AG
Colorectal Dis; 2018 Jul; 20(7):574-585. PubMed ID: 29582537
[TBL] [Abstract][Full Text] [Related]
32. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
33. Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients.
Zhang RX; Zhou ZG; Lu SX; Lu ZH; Wan DS; Pan ZZ; Wu XJ; Chen G
Sci Rep; 2017 Nov; 7(1):16043. PubMed ID: 29167471
[TBL] [Abstract][Full Text] [Related]
34. Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?
Geva R; Davidovics H; Soyfer S; Pelles-Avraham S; Klausner JM; Inbar M; Tulchinsky H
Colorectal Dis; 2017 Mar; 19(3):237-242. PubMed ID: 27474791
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma.
Peng H; You K; Zhang R; Xi S; Zhang T; Dong J; Cai M; Wang C; Zhang H; Zhou T; Gao Y; Wen B
Oncotarget; 2016 Jun; 7(23):35233-40. PubMed ID: 27153549
[TBL] [Abstract][Full Text] [Related]
36. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
[TBL] [Abstract][Full Text] [Related]
37. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
38. Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients.
Troncarelli Flores BC; Souza E Silva V; Ali Abdallah E; Mello CAL; Gobo Silva ML; Gomes Mendes G; Camila Braun A; Aguiar Junior S; Thomé Domingos Chinen L
Cells; 2019 Jun; 8(7):. PubMed ID: 31247977
[TBL] [Abstract][Full Text] [Related]
39. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
Ryan JE; Warrier SK; Lynch AC; Heriot AG
Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Ho SSK; Hon SSF; Hung E; Lee JFY; Mo F; Tong M; So C; Chu S; Ng DCK; Lam D; Cho C; Mak TWC; Ng SSM; Futaba K; Suen J; To KF; Chan AWH; Yeung WWK; Ma BBY
Hong Kong Med J; 2022 Jun; 28(3):230-238. PubMed ID: 35667869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]